HEADER TRANSPORT PROTEIN 14-JUN-10 2XHD TITLE CRYSTAL STRUCTURE OF N-((2S)-5-(6-FLUORO-3-PYRIDINYL)-2,3-DIHYDRO-1H- TITLE 2 INDEN-2-YL)-2-PROPANESULFONAMIDE IN COMPLEX WITH THE LIGAND BINDING TITLE 3 DOMAIN OF THE HUMAN GLUA2 RECEPTOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMATE RECEPTOR 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 412-427 AND 653-796; COMPND 5 SYNONYM: GLUR-B, GLUR-K2, GLUTAMATE RECEPTOR IONOTROPIC AMPA 2, COMPND 6 GLUA2, AMPA-SELECTIVE GLUTAMATE RECEPTOR 2; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: THIS IS AN S1-S2 FUSION IN WHICH GLY 118 AND THR 119 COMPND 9 REPLACE A MEMBRANE SPANNING REGION. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS TRANSPORT PROTEIN, ION CHANNEL EXPDTA X-RAY DIFFRACTION AUTHOR S.E.WARD,M.HARRIES,L.ALDEGHERI,D.ANDREOTTI,S.BALLANTINE,B.D.BAX, AUTHOR 2 A.J.HARRIS,A.J.HARKER,J.LUND,R.MELARANGE,A.MINGARDI,C.MOOKHERJEE, AUTHOR 3 J.MOSLEY,M.NEVE,B.OLIOSI,R.PROFETA,K.J.SMITH,P.W.SMITH,S.SPADA, AUTHOR 4 K.M.THEWLIS,S.P.YUSAF REVDAT 3 20-NOV-24 2XHD 1 REMARK REVDAT 2 01-JUN-11 2XHD 1 JRNL REMARK REVDAT 1 21-JUL-10 2XHD 0 JRNL AUTH S.E.WARD,M.HARRIES,L.ALDEGHERI,D.ANDREOTTI,S.BALLANTINE, JRNL AUTH 2 B.D.BAX,A.J.HARRIS,A.J.HARKER,J.LUND,R.MELARANGE,A.MINGARDI, JRNL AUTH 3 C.MOOKHERJEE,J.MOSLEY,M.NEVE,B.OLIOSI,R.PROFETA,K.J.SMITH, JRNL AUTH 4 P.W.SMITH,S.SPADA,K.M.THEWLIS,S.P.YUSAF JRNL TITL DISCOVERY OF JRNL TITL 2 N-[(2S)-5-(6-FLUORO-3-PYRIDINYL)-2, JRNL TITL 3 3-DIHYDRO-1H-INDEN-2-YL]-2-PROPANESULFONAMIDE, A NOVEL JRNL TITL 4 CLINICAL AMPA RECEPTOR POSITIVE MODULATOR. JRNL REF J.MED.CHEM. V. 53 5801 2010 JRNL REFN ISSN 0022-2623 JRNL PMID 20614889 JRNL DOI 10.1021/JM1005429 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 50730 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2702 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3574 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2460 REMARK 3 BIN FREE R VALUE SET COUNT : 194 REMARK 3 BIN FREE R VALUE : 0.2750 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4018 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 545 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.83000 REMARK 3 B22 (A**2) : -1.20000 REMARK 3 B33 (A**2) : -1.63000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.144 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.135 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.093 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.992 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4383 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5943 ; 1.063 ; 1.993 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 556 ; 4.745 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 171 ;28.594 ;24.269 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 819 ;11.165 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;14.443 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 640 ; 0.071 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3309 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2688 ; 0.710 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4357 ; 1.504 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1695 ; 2.272 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1586 ; 3.630 ; 8.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. COMPOUND 7T9 ON POCKET ON NCS TWOFOLD AXIS THE REMARK 3 OCCUPANCY FOR THE COMPOUND AND SOME ASSOCIATED WATERS AND SIDE- REMARK 3 CHAINS ARE 0.5. WATERS 3000-3003 ARE ASSOCIATED ASSOCIATED WITH REMARK 3 CONFORMER B, 3004-3007 WITH CONFORMER A REMARK 4 REMARK 4 2XHD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-JUN-10. REMARK 100 THE DEPOSITION ID IS D_1290044240. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9393 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53509 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 49.56950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 60.89050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 49.56950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 60.89050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -72.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 ALA A 2 REMARK 465 GLY B 1 REMARK 465 ALA B 2 REMARK 465 ASN B 3 REMARK 465 LYS B 258 REMARK 465 GLY B 259 REMARK 465 GLU B 260 REMARK 465 ALA B 263 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 4 CG CD CE NZ REMARK 470 LYS A 69 CG CD CE NZ REMARK 470 LYS A 258 CG CD CE NZ REMARK 470 ALA A 263 CA C O CB REMARK 470 LYS B 4 CG CD CE NZ REMARK 470 LYS B 183 CG CD CE NZ REMARK 470 GLY B 262 CA C O REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 N-[(2S)-5-(6-FLUORO-3-PYRIDINYL)-2, REMARK 600 3-DIHYDRO-1H-INDEN-2-YL]-2-PROPANESULFONAMIDE (7T9): REMARK 600 COMPOUND SITS ON NON-CRYSTALLOGRAPHIC TWOFOLD. TWO REMARK 600 EQUIVALENT BINDING MODES ARE OBSEREVED. REMARK 600 GLUTAMATE (GLU): GLUTAMATE IS THE LIGAND FOR THE RECEPTOR. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GLU A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1264 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1265 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GLU B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1263 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1264 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1265 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7T9 B 1266 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2WJX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN IONOTROPIC GLUTAMATE RECEPTOR GLUR2 REMARK 900 ATD REGION AT 4.1 A RESOLUTION REMARK 900 RELATED ID: 2WJW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN IONOTROPIC GLUTAMATE RECEPTOR GLUR2 REMARK 900 ATD REGION AT 1.8 A RESOLUTION REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS IS AN S1-S2 FUSION IN WHICH GLY 118 AND THR 119 REMARK 999 REPLACE A MEMBRANE SPANNING REGION. DBREF 2XHD A 2 117 UNP P42262 GRIA2_HUMAN 412 527 DBREF 2XHD A 118 119 PDB 2XHD 2XHD 118 119 DBREF 2XHD A 120 263 UNP P42262 GRIA2_HUMAN 653 796 DBREF 2XHD B 2 117 UNP P42262 GRIA2_HUMAN 412 527 DBREF 2XHD B 118 119 PDB 2XHD 2XHD 118 119 DBREF 2XHD B 120 263 UNP P42262 GRIA2_HUMAN 653 796 SEQADV 2XHD GLY A 1 UNP P42262 EXPRESSION TAG SEQADV 2XHD ALA A 2 UNP P42262 EXPRESSION TAG SEQADV 2XHD SER A 242 UNP P42262 ASN 775 VARIANT SEQADV 2XHD GLY B 1 UNP P42262 EXPRESSION TAG SEQADV 2XHD ALA A 2 UNP P42262 EXPRESSION TAG SEQADV 2XHD SER A 242 UNP P42262 ASN 775 VARIANT SEQRES 1 A 263 GLY ALA ASN LYS THR VAL VAL VAL THR THR ILE LEU GLU SEQRES 2 A 263 SER PRO TYR VAL MET MET LYS LYS ASN HIS GLU MET LEU SEQRES 3 A 263 GLU GLY ASN GLU ARG TYR GLU GLY TYR CYS VAL ASP LEU SEQRES 4 A 263 ALA ALA GLU ILE ALA LYS HIS CYS GLY PHE LYS TYR LYS SEQRES 5 A 263 LEU THR ILE VAL GLY ASP GLY LYS TYR GLY ALA ARG ASP SEQRES 6 A 263 ALA ASP THR LYS ILE TRP ASN GLY MET VAL GLY GLU LEU SEQRES 7 A 263 VAL TYR GLY LYS ALA ASP ILE ALA ILE ALA PRO LEU THR SEQRES 8 A 263 ILE THR LEU VAL ARG GLU GLU VAL ILE ASP PHE SER LYS SEQRES 9 A 263 PRO PHE MET SER LEU GLY ILE SER ILE MET ILE LYS LYS SEQRES 10 A 263 GLY THR PRO ILE GLU SER ALA GLU ASP LEU SER LYS GLN SEQRES 11 A 263 THR GLU ILE ALA TYR GLY THR LEU ASP SER GLY SER THR SEQRES 12 A 263 LYS GLU PHE PHE ARG ARG SER LYS ILE ALA VAL PHE ASP SEQRES 13 A 263 LYS MET TRP THR TYR MET ARG SER ALA GLU PRO SER VAL SEQRES 14 A 263 PHE VAL ARG THR THR ALA GLU GLY VAL ALA ARG VAL ARG SEQRES 15 A 263 LYS SER LYS GLY LYS TYR ALA TYR LEU LEU GLU SER THR SEQRES 16 A 263 MET ASN GLU TYR ILE GLU GLN ARG LYS PRO CYS ASP THR SEQRES 17 A 263 MET LYS VAL GLY GLY ASN LEU ASP SER LYS GLY TYR GLY SEQRES 18 A 263 ILE ALA THR PRO LYS GLY SER SER LEU ARG THR PRO VAL SEQRES 19 A 263 ASN LEU ALA VAL LEU LYS LEU SER GLU GLN GLY VAL LEU SEQRES 20 A 263 ASP LYS LEU LYS ASN LYS TRP TRP TYR ASP LYS GLY GLU SEQRES 21 A 263 CYS GLY ALA SEQRES 1 B 263 GLY ALA ASN LYS THR VAL VAL VAL THR THR ILE LEU GLU SEQRES 2 B 263 SER PRO TYR VAL MET MET LYS LYS ASN HIS GLU MET LEU SEQRES 3 B 263 GLU GLY ASN GLU ARG TYR GLU GLY TYR CYS VAL ASP LEU SEQRES 4 B 263 ALA ALA GLU ILE ALA LYS HIS CYS GLY PHE LYS TYR LYS SEQRES 5 B 263 LEU THR ILE VAL GLY ASP GLY LYS TYR GLY ALA ARG ASP SEQRES 6 B 263 ALA ASP THR LYS ILE TRP ASN GLY MET VAL GLY GLU LEU SEQRES 7 B 263 VAL TYR GLY LYS ALA ASP ILE ALA ILE ALA PRO LEU THR SEQRES 8 B 263 ILE THR LEU VAL ARG GLU GLU VAL ILE ASP PHE SER LYS SEQRES 9 B 263 PRO PHE MET SER LEU GLY ILE SER ILE MET ILE LYS LYS SEQRES 10 B 263 GLY THR PRO ILE GLU SER ALA GLU ASP LEU SER LYS GLN SEQRES 11 B 263 THR GLU ILE ALA TYR GLY THR LEU ASP SER GLY SER THR SEQRES 12 B 263 LYS GLU PHE PHE ARG ARG SER LYS ILE ALA VAL PHE ASP SEQRES 13 B 263 LYS MET TRP THR TYR MET ARG SER ALA GLU PRO SER VAL SEQRES 14 B 263 PHE VAL ARG THR THR ALA GLU GLY VAL ALA ARG VAL ARG SEQRES 15 B 263 LYS SER LYS GLY LYS TYR ALA TYR LEU LEU GLU SER THR SEQRES 16 B 263 MET ASN GLU TYR ILE GLU GLN ARG LYS PRO CYS ASP THR SEQRES 17 B 263 MET LYS VAL GLY GLY ASN LEU ASP SER LYS GLY TYR GLY SEQRES 18 B 263 ILE ALA THR PRO LYS GLY SER SER LEU ARG THR PRO VAL SEQRES 19 B 263 ASN LEU ALA VAL LEU LYS LEU SER GLU GLN GLY VAL LEU SEQRES 20 B 263 ASP LYS LEU LYS ASN LYS TRP TRP TYR ASP LYS GLY GLU SEQRES 21 B 263 CYS GLY ALA HET GLU A 301 10 HET SO4 A1264 5 HET SO4 A1265 5 HET GLU B 301 10 HET 7T9 B1266 46 HET SO4 B1263 5 HET SO4 B1264 5 HET SO4 B1265 5 HETNAM GLU GLUTAMIC ACID HETNAM SO4 SULFATE ION HETNAM 7T9 N-[(2S)-5-(6-FLUORO-3-PYRIDINYL)-2,3-DIHYDRO-1H-INDEN- HETNAM 2 7T9 2-YL]-2-PROPANESULFONAMIDE FORMUL 3 GLU 2(C5 H9 N O4) FORMUL 4 SO4 5(O4 S 2-) FORMUL 7 7T9 C17 H19 F N2 O2 S FORMUL 11 HOH *545(H2 O) HELIX 1 1 GLU A 27 GLU A 30 5 4 HELIX 2 2 GLY A 34 GLY A 48 1 15 HELIX 3 3 ASN A 72 TYR A 80 1 9 HELIX 4 4 THR A 93 GLU A 98 1 6 HELIX 5 5 SER A 123 LYS A 129 1 7 HELIX 6 6 GLY A 141 SER A 150 1 10 HELIX 7 7 ILE A 152 ALA A 165 1 14 HELIX 8 8 THR A 173 SER A 184 1 12 HELIX 9 9 SER A 194 GLN A 202 1 9 HELIX 10 10 LEU A 230 GLN A 244 1 15 HELIX 11 11 GLY A 245 TRP A 255 1 11 HELIX 12 12 ASN B 22 LEU B 26 5 5 HELIX 13 13 GLU B 27 GLU B 30 5 4 HELIX 14 14 GLY B 34 GLY B 48 1 15 HELIX 15 15 ASN B 72 TYR B 80 1 9 HELIX 16 16 THR B 93 GLU B 98 1 6 HELIX 17 17 SER B 123 LYS B 129 1 7 HELIX 18 18 GLY B 141 SER B 150 1 10 HELIX 19 19 ILE B 152 ALA B 165 1 14 HELIX 20 20 THR B 173 SER B 184 1 12 HELIX 21 21 SER B 194 GLN B 202 1 9 HELIX 22 22 LEU B 230 GLN B 244 1 15 HELIX 23 23 GLY B 245 TYR B 256 1 12 SHEET 1 AA 3 TYR A 51 ILE A 55 0 SHEET 2 AA 3 VAL A 6 THR A 10 1 O VAL A 6 N LYS A 52 SHEET 3 AA 3 ILE A 85 ALA A 86 1 O ILE A 85 N THR A 9 SHEET 1 AB 2 MET A 18 MET A 19 0 SHEET 2 AB 2 TYR A 32 GLU A 33 -1 O GLU A 33 N MET A 18 SHEET 1 AC 2 ILE A 100 PHE A 102 0 SHEET 2 AC 2 ALA A 223 PRO A 225 -1 O THR A 224 N ASP A 101 SHEET 1 AD 2 MET A 107 LEU A 109 0 SHEET 2 AD 2 LYS A 218 TYR A 220 -1 O LYS A 218 N LEU A 109 SHEET 1 AE 4 ALA A 134 GLY A 136 0 SHEET 2 AE 4 TYR A 188 GLU A 193 1 O ALA A 189 N GLY A 136 SHEET 3 AE 4 ILE A 111 LYS A 116 -1 O SER A 112 N LEU A 192 SHEET 4 AE 4 THR A 208 VAL A 211 -1 O MET A 209 N ILE A 115 SHEET 1 BA 3 TYR B 51 ILE B 55 0 SHEET 2 BA 3 VAL B 6 THR B 10 1 O VAL B 6 N LYS B 52 SHEET 3 BA 3 ILE B 85 ALA B 86 1 O ILE B 85 N THR B 9 SHEET 1 BB 2 MET B 18 MET B 19 0 SHEET 2 BB 2 TYR B 32 GLU B 33 -1 O GLU B 33 N MET B 18 SHEET 1 BC 2 ILE B 100 PHE B 102 0 SHEET 2 BC 2 ALA B 223 PRO B 225 -1 O THR B 224 N ASP B 101 SHEET 1 BD 2 MET B 107 LEU B 109 0 SHEET 2 BD 2 LYS B 218 TYR B 220 -1 O LYS B 218 N LEU B 109 SHEET 1 BE 4 ALA B 134 GLY B 136 0 SHEET 2 BE 4 TYR B 188 GLU B 193 1 O ALA B 189 N GLY B 136 SHEET 3 BE 4 ILE B 111 LYS B 116 -1 O SER B 112 N LEU B 192 SHEET 4 BE 4 THR B 208 VAL B 211 -1 O MET B 209 N ILE B 115 SSBOND 1 CYS A 206 CYS A 261 1555 1555 2.03 SSBOND 2 CYS B 206 CYS B 261 1555 1555 2.03 CISPEP 1 SER A 14 PRO A 15 0 -2.13 CISPEP 2 GLU A 166 PRO A 167 0 -2.64 CISPEP 3 GLU A 166 PRO A 167 0 -2.14 CISPEP 4 LYS A 204 PRO A 205 0 5.42 CISPEP 5 SER B 14 PRO B 15 0 -0.57 CISPEP 6 GLU B 166 PRO B 167 0 -3.31 CISPEP 7 LYS B 204 PRO B 205 0 4.84 CISPEP 8 LYS B 204 PRO B 205 0 4.56 SITE 1 AC1 13 TYR A 61 PRO A 89 LEU A 90 THR A 91 SITE 2 AC1 13 ARG A 96 GLY A 141 SER A 142 THR A 143 SITE 3 AC1 13 GLU A 193 TYR A 220 HOH A2148 HOH A2205 SITE 4 AC1 13 HOH A2283 SITE 1 AC2 7 SER A 140 LYS A 144 ARG A 148 HOH A2150 SITE 2 AC2 7 HOH A2284 HOH A2285 HOH A2286 SITE 1 AC3 3 ARG A 148 TRP A 159 ARG A 163 SITE 1 AC4 13 TYR B 61 PRO B 89 LEU B 90 THR B 91 SITE 2 AC4 13 ARG B 96 GLY B 141 SER B 142 THR B 143 SITE 3 AC4 13 GLU B 193 TYR B 220 HOH B2138 HOH B2185 SITE 4 AC4 13 HOH B2245 SITE 1 AC5 8 ASP B 139 SER B 140 LYS B 144 ARG B 148 SITE 2 AC5 8 HOH B2081 HOH B2246 HOH B2247 HOH B2248 SITE 1 AC6 5 LYS A 183 ARG B 31 HOH B2040 HOH B2249 SITE 2 AC6 5 HOH B2250 SITE 1 AC7 4 ARG B 148 TRP B 159 ARG B 163 HOH B2251 SITE 1 AC8 26 LYS A 104 PRO A 105 MET A 107 SER A 108 SITE 2 AC8 26 SER A 217 LYS A 218 GLY A 219 SER A 242 SITE 3 AC8 26 HOH A2234 HOH A2257 LYS B 104 PRO B 105 SITE 4 AC8 26 MET B 107 SER B 108 SER B 217 LYS B 218 SITE 5 AC8 26 GLY B 219 SER B 242 HOH B3000 HOH B3001 SITE 6 AC8 26 HOH B3002 HOH B3003 HOH B3004 HOH B3005 SITE 7 AC8 26 HOH B3006 HOH B3007 CRYST1 99.139 121.781 47.490 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010087 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008211 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021057 0.00000